A. Apostoli

发表

Clonal evolution and tumor-initiating cells: New dimensions in cancer patient treatment

L. Ailles, A. Apostoli, 2016, Critical reviews in clinical laboratory sciences.

Efficient generation of patient-matched malignant and normal primary cell cultures from clear cell renal cell carcinoma patients: clinically relevant models for research and personalized medicine

J. Moffat, A. Zlotta, A. Finelli, 2016, BMC Cancer.

Opposing roles for mammary epithelial-specific PPARγ signaling and activation during breast tumour progression

C. Nicol, S. Sengupta, A. Apostoli, 2015, Molecular Cancer.

Loss of PPARγ expression in mammary secretory epithelial cells creates a pro-breast tumorigenic environment

C. Nicol, S. Sengupta, A. Apostoli, 2013, International journal of cancer.

PPAR Medicines and Human Disease: The ABCs of It All

Christopher J. B. Nicol, C. Nicol, A. Apostoli, 2012, PPAR research.

Efficient generation of patient-matched malignant and normal primary cell cultures from clear cell renal cell carcinoma patients: clinically relevant models for research and personalized medicine

A. Evans, J. Moffat, K. Brown, 2016, BMC Cancer.

Stromal adipocyte PPARγ protects against breast tumorigenesis.

C. Nicol, F. Gonzalez, S. Sengupta, 2012, Carcinogenesis.

Atazanavir/ritonavir with lamivudine as maintenance therapy in virologically suppressed HIV-infected patients: 96 week outcomes of a randomized trial

P. Narciso, A. Lazzarin, A. Giacomelli, 2018, The Journal of antimicrobial chemotherapy.

PRMT1 is a critical dependency in clear cell renal cell carcinoma through its role in post-transcriptional regulation of DNA damage response genes

B. Raught, C. Arrowsmith, P. Prinos, 2023, bioRxiv.

PRMT1 inhibition perturbs RNA metabolism and induces DNA damage in clear cell renal cell carcinoma

Christina Karamboulas, Jonathan R St-Germain, A. Apostoli, 2024, Nature communications.